03 · What You Need to Know
“Conditional approval” does not have one universal operational meaning
The phrase sounds self-explanatory, but ethics-review systems can use it differently.
Under OHRP guidance for research governed by the U.S. HHS regulations, "IRB approval with conditions" refers to circumstances in which the IRB is able to make all required approval determinations based on the assumption that specified conditions will be satisfied. The conditions might require specified changes to the protocol or consent documents, confirmation of particular assumptions, or submission of additional documents.
WHO's Research Ethics Review Committee uses "approved conditionally" for a proposal whose approval is contingent on an adequate response by the principal investigator to the satisfaction of the reviewers or Chair. Required amendments are incorporated and resubmitted for scrutiny. WHO states separately that a study receives final approval only after required core documentation has been satisfactorily submitted.
These examples demonstrate why researchers should not infer operational permission from terminology borrowed from another institution.
Conditional approval is not the same as deferral
OHRP draws an important distinction between approval with conditions and deferring or tabling research.
For conditional approval under its guidance, the IRB has already been able to make the determinations required for approval, assuming the specified conditions are met. In contrast, when outstanding issues prevent the IRB from making those determinations, it must defer or table the research for further review rather than call the project approved with conditions. Research that has been deferred may not proceed until the revised project is reviewed and approved.
Approval with conditions
In systems using the OHRP distinction, the committee can make the required approval determinations assuming specified conditions are satisfied.
Deferred or not yet approved
Outstanding issues prevent the committee from making the determinations necessary for approval, so further review is required before approval is granted.
Your committee may use different labels, which is precisely why the decision letter matters more than the label alone.
Conditions can range from simple to consequential
Some conditions may be highly specific: correct a telephone number, insert approved wording into the consent form, provide a missing document, or confirm an assumption about how a procedure will operate.
Others may require more substantial revision: change recruitment, revise a risk-management plan, modify consent, alter data handling, or clarify a methodological feature that affects participant protection.
The nature of the condition can influence who is authorized to verify that it has been satisfied and whether further committee review is needed.
Who checks whether the conditions have been satisfied?
That depends on the review system and the original decision.
OHRP guidance states that when research has been approved with conditions by a convened IRB because the required approval determinations can already be made, the IRB may designate the chairperson or another appropriately qualified individual to review the investigator's responsive materials and determine that the conditions have been satisfied. Another convened meeting is not necessarily required.
WHO's process similarly states that responses to conditional approval may be scrutinized by the Secretariat or primary reviewers as determined by the committee.
You do not decide for yourself that the condition has been satisfied simply because you made the requested edit.
Submitting the revision is not necessarily the same as satisfying the condition
Imagine that the committee requires you to clarify data retention. You upload a revised protocol five minutes later.
Your action is complete. The review process may not be.
The responsible reviewer may still need to determine whether the revision actually addresses the condition. If the response introduces another inconsistency or does not fully resolve the concern, further revision may be necessary.
This is why a clear response to committee comments and conditions should show exactly what was changed and where.
Can research start before the conditions are verified?
Do not answer this question from the phrase "conditional approval" alone.
Check the decision letter for explicit statements such as whether recruitment may begin, whether participant contact is prohibited, whether data collection must wait, whether only administrative preparations are permitted, or whether final confirmation will be issued after the conditions are satisfied.
WHO's own ERC process provides a useful example of a system in which conditional approval remains contingent on an adequate response and final approval follows satisfactory submission of required documentation.
OHRP's concept of approval with conditions is technically different, but institutional procedures still govern how conditions are verified and how the effective date and authorization are communicated. OHRP's current written-procedures guidance recommends that IRBs document the effective date of initial approval and communicate findings and actions to investigators.
Watch Out
If the decision letter does not clearly tell you whether recruitment or other participant-facing activities may begin, ask the responsible ethics office. Do not convert ambiguity into permission.
Do not assume unaffected parts of the study can begin
Suppose the only outstanding condition concerns the interview guide. Can you begin recruiting participants while the guide is being revised?
Perhaps, but only if the committee's decision and institutional procedures permit it.
Recruitment itself can be an ethically reviewed research activity. Beginning recruitment may expose prospective participants to approved materials, collect contact information, or initiate screening. The fact that the unresolved condition concerns a later procedure does not automatically authorize earlier stages.
Likewise, "we will only collect baseline data" is not a safe workaround if baseline collection remains part of research that is not yet authorized to begin.
Administrative preparation and human-participant activity are not necessarily the same
Some work may occur before participant research begins, depending on institutional rules. Researchers might prepare databases, train staff, organize equipment, complete contracts, or perform other non-participant activities.
Do not assume every preparatory activity is automatically permitted, particularly if it involves accessing identifiable records, identifying prospective participants, screening people, or using data that require ethics authorization.
If timing matters, ask which preparations can legitimately proceed while the conditions are being resolved.
The conditions must be incorporated into the controlled study documents
If the committee requires a change, the approved study documents should ultimately reflect that change.
WHO's submission guidance instructs investigators to incorporate requested amendments into the protocol and submit the revised material with changes marked during review. After approval, a final clean protocol is submitted.
Whatever your committee's version-control system, the research team should be able to identify the protocol, consent forms, instruments, recruitment materials, and other documents that are actually authorized for use.
A condition can affect more documents than the one named
If the committee asks you to change the duration of participation, the revision may belong in the protocol, consent form, participant information sheet, recruitment advertisement, and study schedule.
If a risk statement changes, participant-facing materials may also need revision. If recruitment changes, consent logistics may need another look.
Do not satisfy a condition in one document while leaving the rest of the submission describing the old study.
Do not add unrelated modifications while satisfying conditions without disclosing them
A conditional response is not a convenient opportunity to redesign unrelated parts of the study quietly.
Under U.S. HHS and FDA requirements discussed in OHRP's current written-procedures guidance, changes to already approved research generally may not be initiated without prior IRB review and approval except where necessary to eliminate apparent immediate hazards.
If you need to make an additional substantive change, identify it and follow the committee's procedure rather than burying it among the requested conditions.
Conditional approval can have a defined effective date
The date on which approval becomes effective can matter for determining when research activities are authorized and when any approval period begins.
OHRP's written-procedures guidance recommends that IRBs subject to the relevant regulations have procedures for determining and documenting the effective date of initial approval and, where continuing review applies, calculating subsequent review dates.
Do not assume that the date of the committee meeting, the date of the conditional letter, the date you submit revisions, and the date final confirmation is issued are interchangeable.
Other approvals may still be outstanding
Even final ethics approval may not be the only authorization a study needs.
WHO's ERC, for example, requires local ethics approval as part of the core documentation before final WHO ERC approval for studies within its remit.
Depending on your study, site permission, institutional authorization, data-access approval, regulatory authorization, sponsor clearance, contracts, or other requirements may also remain.
This is why the next question after receiving any approval letter should be broader than "Did the ethics committee say yes?" You also need to check whether the approval letter and other requirements actually permit the study to begin.
